Global and United States Angiotensin II Receptor Blockers Market Insights, Forecast to 2027

Publisher Name :
Date: 22-Oct-2021
No. of pages: 138
Inquire Before Buying

Angiotensin II Receptor Blockers market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Angiotensin II Receptor Blockers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For United States market, this report focuses on the Angiotensin II Receptor Blockers market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

- Azilsartan

- Candesartan

- Eprosartan

- Irbesartan

- Losartan

- Olmesartan

- Telmisartan

- Valsartan

Segment by Application

- Chronic Kidney Diseases

- Heart Failure

- Kidney Failure in Diabetes

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Merck & Co.

- AstraZeneca

- Novartis

- Teva

- Bayer

- GlaxoSmithKline

- Sun Pharmaceutical

- Mylan

Global and United States Angiotensin II Receptor Blockers Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Angiotensin II Receptor Blockers Product Introduction
1.2 Market by Type
1.2.1 Global Angiotensin II Receptor Blockers Market Size Growth Rate by Type
1.2.2 Azilsartan
1.2.3 Candesartan
1.2.4 Eprosartan
1.2.5 Irbesartan
1.2.6 Losartan
1.2.7 Olmesartan
1.2.8 Telmisartan
1.2.9 Valsartan
1.3 Market by Application
1.3.1 Global Angiotensin II Receptor Blockers Market Size Growth Rate by Application
1.3.2 Chronic Kidney Diseases
1.3.3 Heart Failure
1.3.4 Kidney Failure in Diabetes
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Angiotensin II Receptor Blockers Market Size, Estimates and Forecasts
2.1.1 Global Angiotensin II Receptor Blockers Revenue 2016-2027
2.1.2 Global Angiotensin II Receptor Blockers Sales 2016-2027
2.2 Global Angiotensin II Receptor Blockers, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Angiotensin II Receptor Blockers Historical Market Size by Region (2016-2021)
2.3.1 Global Angiotensin II Receptor Blockers Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Angiotensin II Receptor Blockers Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Angiotensin II Receptor Blockers Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Angiotensin II Receptor Blockers Sales Forecast by Region (2022-2027)
2.4.2 Global Angiotensin II Receptor Blockers Revenue Forecast by Region (2022-2027)
3 Global Angiotensin II Receptor Blockers Competitor Landscape by Players
3.1 Global Top Angiotensin II Receptor Blockers Manufacturers by Sales
3.1.1 Global Angiotensin II Receptor Blockers Sales by Manufacturer (2016-2021)
3.1.2 Global Angiotensin II Receptor Blockers Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Angiotensin II Receptor Blockers Manufacturers by Revenue
3.2.1 Key Angiotensin II Receptor Blockers Manufacturers Covered: Ranking by Revenue
3.2.2 Global Angiotensin II Receptor Blockers Revenue by Manufacturers (2016-2021)
3.2.3 Global Angiotensin II Receptor Blockers Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Angiotensin II Receptor Blockers Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Angiotensin II Receptor Blockers Revenue in 2020
3.2.6 Global Angiotensin II Receptor Blockers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Angiotensin II Receptor Blockers Price by Manufacturers
3.4 Global Angiotensin II Receptor Blockers Manufacturing Base Distribution, Product Types
3.4.1 Angiotensin II Receptor Blockers Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Angiotensin II Receptor Blockers Product Type
3.4.3 Date of International Manufacturers Enter into Angiotensin II Receptor Blockers Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Angiotensin II Receptor Blockers Market Size by Type (2016-2021)
4.1.1 Global Angiotensin II Receptor Blockers Sales by Type (2016-2021)
4.1.2 Global Angiotensin II Receptor Blockers Revenue by Type (2016-2021)
4.1.3 Angiotensin II Receptor Blockers Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Angiotensin II Receptor Blockers Market Size Forecast by Type (2022-2027)
4.2.1 Global Angiotensin II Receptor Blockers Sales Forecast by Type (2022-2027)
4.2.2 Global Angiotensin II Receptor Blockers Revenue Forecast by Type (2022-2027)
4.2.3 Angiotensin II Receptor Blockers Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Angiotensin II Receptor Blockers Market Size by Application (2016-2021)
5.1.1 Global Angiotensin II Receptor Blockers Sales by Application (2016-2021)
5.1.2 Global Angiotensin II Receptor Blockers Revenue by Application (2016-2021)
5.1.3 Angiotensin II Receptor Blockers Price by Application (2016-2021)
5.2 Angiotensin II Receptor Blockers Market Size Forecast by Application (2022-2027)
5.2.1 Global Angiotensin II Receptor Blockers Sales Forecast by Application (2022-2027)
5.2.2 Global Angiotensin II Receptor Blockers Revenue Forecast by Application (2022-2027)
5.2.3 Global Angiotensin II Receptor Blockers Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Angiotensin II Receptor Blockers Market Size YoY Growth 2016-2027
6.1.1 United States Angiotensin II Receptor Blockers Sales YoY Growth 2016-2027
6.1.2 United States Angiotensin II Receptor Blockers Revenue YoY Growth 2016-2027
6.1.3 United States Angiotensin II Receptor Blockers Market Share in Global Market 2016-2027
6.2 United States Angiotensin II Receptor Blockers Market Size by Players (International and Local Players)
6.2.1 United States Top Angiotensin II Receptor Blockers Players by Sales (2016-2021)
6.2.2 United States Top Angiotensin II Receptor Blockers Players by Revenue (2016-2021)
6.3 United States Angiotensin II Receptor Blockers Historic Market Review by Type (2016-2021)
6.3.1 United States Angiotensin II Receptor Blockers Sales Market Share by Type (2016-2021)
6.3.2 United States Angiotensin II Receptor Blockers Revenue Market Share by Type (2016-2021)
6.3.3 United States Angiotensin II Receptor Blockers Price by Type (2016-2021)
6.4 United States Angiotensin II Receptor Blockers Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Angiotensin II Receptor Blockers Sales Forecast by Type (2022-2027)
6.4.2 United States Angiotensin II Receptor Blockers Revenue Forecast by Type (2022-2027)
6.4.3 United States Angiotensin II Receptor Blockers Price Forecast by Type (2022-2027)
6.5 United States Angiotensin II Receptor Blockers Historic Market Review by Application (2016-2021)
6.5.1 United States Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2021)
6.5.2 United States Angiotensin II Receptor Blockers Revenue Market Share by Application (2016-2021)
6.5.3 United States Angiotensin II Receptor Blockers Price by Application (2016-2021)
6.6 United States Angiotensin II Receptor Blockers Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Angiotensin II Receptor Blockers Sales Forecast by Application (2022-2027)
6.6.2 United States Angiotensin II Receptor Blockers Revenue Forecast by Application (2022-2027)
6.6.3 United States Angiotensin II Receptor Blockers Price Forecast by Application (2022-2027)
7 North America
7.1 North America Angiotensin II Receptor Blockers Market Size YoY Growth 2016-2027
7.2 North America Angiotensin II Receptor Blockers Market Facts & Figures by Country
7.2.1 North America Angiotensin II Receptor Blockers Sales by Country (2016-2021)
7.2.2 North America Angiotensin II Receptor Blockers Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Angiotensin II Receptor Blockers Market Size YoY Growth 2016-2027
8.2 Asia Pacific Angiotensin II Receptor Blockers Market Facts & Figures by Region
8.2.1 Asia Pacific Angiotensin II Receptor Blockers Sales by Region (2016-2021)
8.2.2 Asia Pacific Angiotensin II Receptor Blockers Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Angiotensin II Receptor Blockers Market Size YoY Growth 2016-2027
9.2 Europe Angiotensin II Receptor Blockers Market Facts & Figures by Country
9.2.1 Europe Angiotensin II Receptor Blockers Sales by Country (2016-2021)
9.2.2 Europe Angiotensin II Receptor Blockers Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Angiotensin II Receptor Blockers Market Size YoY Growth 2016-2027
10.2 Latin America Angiotensin II Receptor Blockers Market Facts & Figures by Country
10.2.1 Latin America Angiotensin II Receptor Blockers Sales by Country (2016-2021)
10.2.2 Latin America Angiotensin II Receptor Blockers Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Angiotensin II Receptor Blockers Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Angiotensin II Receptor Blockers Market Facts & Figures by Country
11.2.1 Middle East and Africa Angiotensin II Receptor Blockers Sales by Country (2016-2021)
11.2.2 Middle East and Africa Angiotensin II Receptor Blockers Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Merck & Co.
12.1.1 Merck & Co. Corporation Information
12.1.2 Merck & Co. Description and Business Overview
12.1.3 Merck & Co. Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck & Co. Angiotensin II Receptor Blockers Products Offered
12.1.5 Merck & Co. Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Description and Business Overview
12.2.3 AstraZeneca Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca Angiotensin II Receptor Blockers Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Description and Business Overview
12.3.3 Novartis Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Angiotensin II Receptor Blockers Products Offered
12.3.5 Novartis Recent Development
12.4 Teva
12.4.1 Teva Corporation Information
12.4.2 Teva Description and Business Overview
12.4.3 Teva Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Teva Angiotensin II Receptor Blockers Products Offered
12.4.5 Teva Recent Development
12.5 Bayer
12.5.1 Bayer Corporation Information
12.5.2 Bayer Description and Business Overview
12.5.3 Bayer Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bayer Angiotensin II Receptor Blockers Products Offered
12.5.5 Bayer Recent Development
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Corporation Information
12.6.2 GlaxoSmithKline Description and Business Overview
12.6.3 GlaxoSmithKline Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.6.4 GlaxoSmithKline Angiotensin II Receptor Blockers Products Offered
12.6.5 GlaxoSmithKline Recent Development
12.7 Sun Pharmaceutical
12.7.1 Sun Pharmaceutical Corporation Information
12.7.2 Sun Pharmaceutical Description and Business Overview
12.7.3 Sun Pharmaceutical Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sun Pharmaceutical Angiotensin II Receptor Blockers Products Offered
12.7.5 Sun Pharmaceutical Recent Development
12.8 Mylan
12.8.1 Mylan Corporation Information
12.8.2 Mylan Description and Business Overview
12.8.3 Mylan Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Mylan Angiotensin II Receptor Blockers Products Offered
12.8.5 Mylan Recent Development
12.11 Merck & Co.
12.11.1 Merck & Co. Corporation Information
12.11.2 Merck & Co. Description and Business Overview
12.11.3 Merck & Co. Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merck & Co. Angiotensin II Receptor Blockers Products Offered
12.11.5 Merck & Co. Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Angiotensin II Receptor Blockers Industry Trends
13.2 Angiotensin II Receptor Blockers Market Drivers
13.3 Angiotensin II Receptor Blockers Market Challenges
13.4 Angiotensin II Receptor Blockers Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Angiotensin II Receptor Blockers Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Angiotensin II Receptor Blockers Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Azilsartan
Table 3. Major Manufacturers of Candesartan
Table 4. Major Manufacturers of Eprosartan
Table 5. Major Manufacturers of Irbesartan
Table 6. Major Manufacturers of Losartan
Table 7. Major Manufacturers of Olmesartan
Table 8. Major Manufacturers of Telmisartan
Table 9. Major Manufacturers of Valsartan
Table 10. Global Angiotensin II Receptor Blockers Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 11. Global Angiotensin II Receptor Blockers Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 12. Global Angiotensin II Receptor Blockers Sales by Regions (2016-2021) & (K Units)
Table 13. Global Angiotensin II Receptor Blockers Sales Market Share by Regions (2016-2021)
Table 14. Global Angiotensin II Receptor Blockers Revenue by Regions (2016-2021) & (US$ Million)
Table 15. Global Angiotensin II Receptor Blockers Sales Forecast by Region (2022-2027) & (K Units)
Table 16. Global Angiotensin II Receptor Blockers Sales Market Share Forecast by Region (2022-2027)
Table 17. Global Angiotensin II Receptor Blockers Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 18. Global Angiotensin II Receptor Blockers Revenue Market Share Forecast by Region (2022-2027)
Table 19. Global Angiotensin II Receptor Blockers Sales by Manufacturers (2016-2021) (K Units)
Table 20. Global Angiotensin II Receptor Blockers Sales Share by Manufacturers (2016-2021)
Table 21. Ranking of Global Top Angiotensin II Receptor Blockers Manufacturers by Revenue (US$ Million) in 2020
Table 22. Angiotensin II Receptor Blockers Revenue by Manufacturers (2016-2021) (US$ Million)
Table 23. Angiotensin II Receptor Blockers Revenue Share by Manufacturers (2016-2021)
Table 24. Global Angiotensin II Receptor Blockers Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 25. Global Angiotensin II Receptor Blockers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiotensin II Receptor Blockers as of 2020)
Table 26. Key Manufacturers Angiotensin II Receptor Blockers Price (2016-2021) (USD/Unit)
Table 27. Angiotensin II Receptor Blockers Manufacturers Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Angiotensin II Receptor Blockers Product Type
Table 29. Date of International Manufacturers Enter into Angiotensin II Receptor Blockers Market
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 31. Global Angiotensin II Receptor Blockers Sales by Type (2016-2021) (K Units)
Table 32. Global Angiotensin II Receptor Blockers Sales Share by Type (2016-2021)
Table 33. Global Angiotensin II Receptor Blockers Revenue by Type (2016-2021) (US$ Million)
Table 34. Global Angiotensin II Receptor Blockers Revenue Share by Type (2016-2021)
Table 35. Angiotensin II Receptor Blockers Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 36. Global Angiotensin II Receptor Blockers Sales Forecast by Type (2022-2027) & (K Units)
Table 37. Global Angiotensin II Receptor Blockers Sales Market Share Forecast by Type (2022-2027)
Table 38. Global Angiotensin II Receptor Blockers Revenue Forecast V (2022-2027) & (US$ Million)
Table 39. Global Angiotensin II Receptor Blockers Revenue Market Share Forecast by Type (2022-2027)
Table 40. Global Angiotensin II Receptor Blockers Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 41. Global Angiotensin II Receptor Blockers Sales by Application (2016-2021) (K Units)
Table 42. Global Angiotensin II Receptor Blockers Sales Share by Application (2016-2021)
Table 43. Global Angiotensin II Receptor Blockers Revenue by Application (2016-2021) (US$ Million)
Table 44. Global Angiotensin II Receptor Blockers Revenue Share by Application (2016-2021)
Table 45. Angiotensin II Receptor Blockers Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 46. Global Angiotensin II Receptor Blockers Sales Forecast by Application (2022-2027) & (K Units)
Table 47. Global Angiotensin II Receptor Blockers Sales Market Share Forecast by Application (2022-2027)
Table 48. Global Angiotensin II Receptor Blockers Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 49. Global Angiotensin II Receptor Blockers Revenue Market Share Forecast by Application (2022-2027)
Table 50. Global Angiotensin II Receptor Blockers Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 51. United States Angiotensin II Receptor Blockers Sales (K Units) of Key Companies (2016-2021)
Table 52. United States Angiotensin II Receptor Blockers Sales Share by Company (2016-2021)
Table 53. United States Angiotensin II Receptor Blockers Revenue (US$ Million) by Company (2016-2021)
Table 54. United States Angiotensin II Receptor Blockers Revenue Share by Company (2016-2021)
Table 55. United States Angiotensin II Receptor Blockers Sales (K Units) by Type (2016-2021)
Table 56. United States Angiotensin II Receptor Blockers Sales Share by Type (2016-2021)
Table 57. United States Angiotensin II Receptor Blockers Revenue (US$ Million) Market Share by Type (2016-2021)
Table 58. United States Angiotensin II Receptor Blockers Price (USD/Unit) by Type (2016-2021)
Table 59. United States Angiotensin II Receptor Blockers Sales (K Units) by Type (2022-2027)
Table 60. United States Angiotensin II Receptor Blockers Sales Share by Type (2022-2027)
Table 61. United States Angiotensin II Receptor Blockers Revenue (US$ Million) Market Share by Type (2022-2027)
Table 62. United States Angiotensin II Receptor Blockers Revenue Share by Type (2022-2027)
Table 63. United States Angiotensin II Receptor Blockers Price (USD/Unit) by Type (2022-2027)
Table 64. United States Angiotensin II Receptor Blockers Sales (K Units) by Application (2016-2021)
Table 65. United States Angiotensin II Receptor Blockers Sales Share by Application (2016-2021)
Table 66. United States Angiotensin II Receptor Blockers Revenue (US$ Million) Market Share by Application (2016-2021)
Table 67. United States Angiotensin II Receptor Blockers Price (USD/Unit) by Application (2016-2021)
Table 68. United States Angiotensin II Receptor Blockers Sales (K Units) by Application (2022-2027)
Table 69. United States Angiotensin II Receptor Blockers Sales Share by Application (2022-2027)
Table 70. United States Angiotensin II Receptor Blockers Revenue (US$ Million) Market Share by Application (2022-2027)
Table 71. United States Angiotensin II Receptor Blockers Revenue Share by Application (2022-2027)
Table 72. United States Angiotensin II Receptor Blockers Price (USD/Unit) by Application (2022-2027)
Table 73. North America Angiotensin II Receptor Blockers Sales by Country (2016-2021) & (K Units)
Table 74. North America Angiotensin II Receptor Blockers Sales Market Share by Country (2016-2021)
Table 75. North America Angiotensin II Receptor Blockers Revenue by Country (2016-2021) & (US$ Million)
Table 76. North America Angiotensin II Receptor Blockers Revenue Market Share by Country (2016-2021)
Table 77. Asia Pacific Angiotensin II Receptor Blockers Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Angiotensin II Receptor Blockers Sales Market Share by Region (2016-2021)
Table 79. Asia Pacific Angiotensin II Receptor Blockers Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Angiotensin II Receptor Blockers Revenue Market Share by Region (2016-2021)
Table 81. Europe Angiotensin II Receptor Blockers Sales by Country (2016-2021) & (K Units)
Table 82. Europe Angiotensin II Receptor Blockers Sales Market Share by Country (2016-2021)
Table 83. Europe Angiotensin II Receptor Blockers Revenue by Country (2016-2021) & (US$ Million)
Table 84. Europe Angiotensin II Receptor Blockers Revenue Market Share by Country (2016-2021)
Table 85. Latin America Angiotensin II Receptor Blockers Sales by Country (2016-2021) & (K Units)
Table 86. Latin America Angiotensin II Receptor Blockers Sales Market Share by Country (2016-2021)
Table 87. Latin Americaa Angiotensin II Receptor Blockers Revenue by Country (2016-2021) & (US$ Million)
Table 88. Latin America Angiotensin II Receptor Blockers Revenue Market Share by Country (2016-2021)
Table 89. Middle East and Africa Angiotensin II Receptor Blockers Sales by Country (2016-2021) & (K Units)
Table 90. Middle East and Africa Angiotensin II Receptor Blockers Sales Market Share by Country (2016-2021)
Table 91. Middle East and Africa Angiotensin II Receptor Blockers Revenue by Country (2016-2021) & (US$ Million)
Table 92. Middle East and Africa Angiotensin II Receptor Blockers Revenue Market Share by Country (2016-2021)
Table 93. Merck & Co. Corporation Information
Table 94. Merck & Co. Description and Business Overview
Table 95. Merck & Co. Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Merck & Co. Angiotensin II Receptor Blockers Product
Table 97. Merck & Co. Recent Development
Table 98. AstraZeneca Corporation Information
Table 99. AstraZeneca Description and Business Overview
Table 100. AstraZeneca Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. AstraZeneca Product
Table 102. AstraZeneca Recent Development
Table 103. Novartis Corporation Information
Table 104. Novartis Description and Business Overview
Table 105. Novartis Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Novartis Product
Table 107. Novartis Recent Development
Table 108. Teva Corporation Information
Table 109. Teva Description and Business Overview
Table 110. Teva Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Teva Product
Table 112. Teva Recent Development
Table 113. Bayer Corporation Information
Table 114. Bayer Description and Business Overview
Table 115. Bayer Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Bayer Product
Table 117. Bayer Recent Development
Table 118. GlaxoSmithKline Corporation Information
Table 119. GlaxoSmithKline Description and Business Overview
Table 120. GlaxoSmithKline Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. GlaxoSmithKline Product
Table 122. GlaxoSmithKline Recent Development
Table 123. Sun Pharmaceutical Corporation Information
Table 124. Sun Pharmaceutical Description and Business Overview
Table 125. Sun Pharmaceutical Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Sun Pharmaceutical Product
Table 127. Sun Pharmaceutical Recent Development
Table 128. Mylan Corporation Information
Table 129. Mylan Description and Business Overview
Table 130. Mylan Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Mylan Product
Table 132. Mylan Recent Development
Table 133. Angiotensin II Receptor Blockers Market Trends
Table 134. Angiotensin II Receptor Blockers Market Drivers
Table 135. Angiotensin II Receptor Blockers Market Challenges
Table 136. Angiotensin II Receptor Blockers Market Restraints
Table 137. Angiotensin II Receptor Blockers Customers List
Table 138. Angiotensin II Receptor Blockers Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiotensin II Receptor Blockers Product Picture
Figure 2. Global Angiotensin II Receptor Blockers Sales Market Share by Type in 2020 & 2027
Figure 3. Azilsartan Product Picture
Figure 4. Candesartan Product Picture
Figure 5. Eprosartan Product Picture
Figure 6. Irbesartan Product Picture
Figure 7. Losartan Product Picture
Figure 8. Olmesartan Product Picture
Figure 9. Telmisartan Product Picture
Figure 10. Valsartan Product Picture
Figure 11. Global Angiotensin II Receptor Blockers Sales Market Share by Application in 2020 & 2027
Figure 12. Chronic Kidney Diseases
Figure 13. Heart Failure
Figure 14. Kidney Failure in Diabetes
Figure 15. Angiotensin II Receptor Blockers Report Years Considered
Figure 16. Global Angiotensin II Receptor Blockers Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Angiotensin II Receptor Blockers Market Size 2016-2027 (US$ Million)
Figure 18. Global Angiotensin II Receptor Blockers Sales 2016-2027 (K Units)
Figure 19. Global Angiotensin II Receptor Blockers Market Size Market Share by Region: 2021 Versus 2027
Figure 20. Global Angiotensin II Receptor Blockers Sales Market Share by Region (2016-2021)
Figure 21. Global Angiotensin II Receptor Blockers Sales Market Share by Region in 2020
Figure 22. Global Angiotensin II Receptor Blockers Revenue Market Share by Region (2016-2021)
Figure 23. Global Angiotensin II Receptor Blockers Revenue Market Share by Region in 2020
Figure 24. Global Angiotensin II Receptor Blockers Sales Share by Manufacturer in 2020
Figure 25. The Top 10 and 5 Players Market Share by Angiotensin II Receptor Blockers Revenue in 2020
Figure 26. Angiotensin II Receptor Blockers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 27. Global Angiotensin II Receptor Blockers Sales Market Share by Type (2016-2021)
Figure 28. Global Angiotensin II Receptor Blockers Sales Market Share by Type in 2020
Figure 29. Global Angiotensin II Receptor Blockers Revenue Market Share by Type (2016-2021)
Figure 30. Global Angiotensin II Receptor Blockers Revenue Market Share by Type in 2020
Figure 31. Global Angiotensin II Receptor Blockers Sales Market Share by Application (2016-2021)
Figure 32. Global Angiotensin II Receptor Blockers Sales Market Share by Application in 2020
Figure 33. Global Angiotensin II Receptor Blockers Revenue Market Share by Application (2016-2021)
Figure 34. Global Angiotensin II Receptor Blockers Revenue Market Share by Application in 2020
Figure 35. United States Angiotensin II Receptor Blockers Sales Growth Rate 2016-2027 (K Units)
Figure 36. United States Angiotensin II Receptor Blockers Revenue Growth Rate 2016-2027 (US$ Million)
Figure 37. United States Angiotensin II Receptor Blockers Market Share in Global Market 2016-2027
Figure 38. United States 5 and 10 Largest Angiotensin II Receptor Blockers Players Market Share by Revenue in Angiotensin II Receptor Blockers in 2020
Figure 39. United States Angiotensin II Receptor Blockers Revenue Share by Type (2016-2021)
Figure 40. United States Angiotensin II Receptor Blockers Revenue Growth Rate by Type in 2016 & 2020
Figure 41. United States Angiotensin II Receptor Blockers Revenue Share by Application (2016-2021)
Figure 42. United States Angiotensin II Receptor Blockers Revenue Growth Rate by Application in 2016 & 2020
Figure 43. North America Angiotensin II Receptor Blockers Sales Growth Rate 2016-2021 (K Units)
Figure 44. North America Angiotensin II Receptor Blockers Revenue Growth Rate 2016-2021 (US$ Million)
Figure 45. North America Angiotensin II Receptor Blockers Sales Market Share by Country in 2020
Figure 46. North America Angiotensin II Receptor Blockers Revenue Market Share by Country in 2020
Figure 47. U.S. Angiotensin II Receptor Blockers Sales Growth Rate (2016-2021) (K Units)
Figure 48. U.S. Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Canada Angiotensin II Receptor Blockers Sales Growth Rate (2016-2021) (K Units)
Figure 50. Canada Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Europe Angiotensin II Receptor Blockers Sales Growth Rate 2016-2021 (K Units)
Figure 52. Europe Angiotensin II Receptor Blockers Revenue Growth Rate 2016-2021 (US$ Million)
Figure 53. Europe Angiotensin II Receptor Blockers Sales Market Share by Country in 2020
Figure 54. Europe Angiotensin II Receptor Blockers Revenue Market Share by Country in 2020
Figure 55. Germany Angiotensin II Receptor Blockers Sales Growth Rate (2016-2021) (K Units)
Figure 56. Germany Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. France Angiotensin II Receptor Blockers Sales Growth Rate (2016-2021) (K Units)
Figure 58. France Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. U.K. Angiotensin II Receptor Blockers Sales Growth Rate (2016-2021) (K Units)
Figure 60. U.K. Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Italy Angiotensin II Receptor Blockers Sales Growth Rate (2016-2021) (K Units)
Figure 62. Italy Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Russia Angiotensin II Receptor Blockers Sales Growth Rate (2016-2021) (K Units)
Figure 64. Russia Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Asia Pacific Angiotensin II Receptor Blockers Sales Growth Rate 2016-2021 (K Units)
Figure 66. Asia Pacific Angiotensin II Receptor Blockers Revenue Growth Rate 2016-2021 (US$ Million)
Figure 67. Asia Pacific Angiotensin II Receptor Blockers Sales Market Share by Region in 2020
Figure 68. Asia Pacific Angiotensin II Receptor Blockers Revenue Market Share by Region in 2020
Figure 69. China Angiotensin II Receptor Blockers Sales Growth Rate (2016-2021) (K Units)
Figure 70. China Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Japan Angiotensin II Receptor Blockers Sales Growth Rate (2016-2021) (K Units)
Figure 72. Japan Angiotensin II Receptor Blockers Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. South Korea Angiotensin II Receptor Blockers Sales Growth Rate (2016-2021) (K Units)
Figure 74. South Korea Angiotensin I
  • Global and United States Urokinase Injection Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 138
    Urokinase Injection market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Urokinase Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Urokinase......
  • Global and United States Urokinase Lyophilized Powder Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 135
    Urokinase Lyophilized Powder market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Urokinase Lyophilized Powder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuse......
  • Global and Japan Tablet and Capsule Budesonide Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 149
    Tablet and Capsule Budesonide market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Tablet and Capsule Budesonide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on t......
  • Global and China Inhalation Powder Budesonide Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 146
    Inhalation Powder Budesonide market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Inhalation Powder Budesonide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the......
  • Global and United States Aerosols Budesonide Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 148
    Aerosols Budesonide market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Aerosols Budesonide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Aerosols ......
  • Global and United States Injectable Suspension Budesonide Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 148
    Injectable Suspension Budesonide market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Suspension Budesonide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this repor......
  • Global and China Buprenorphine Hydrochloride Tablets Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 145
    Buprenorphine Hydrochloride Tablets market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Buprenorphine Hydrochloride Tablets market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report ......
  • Global and China Buprenorphine Hydrochloride Injection Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 141
    Buprenorphine Hydrochloride Injection market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Buprenorphine Hydrochloride Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this rep......
  • Global and United States Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Market Size, Status and Forecast 2021-2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 117
    Global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs Scope and Market Size Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Granulocyte-Colony Stimulating Factor (G-CSF) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Applicati......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs